BackG1 Therapeutics Overview

G1 Therapeutics Current Cash

G1 Therapeutics's current cash is $15M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$15.07M
↓ 73.04% YoYΔ $-40.84M vs prior year quarter

Peer average

Loading

G1 Therapeutics Current Cash History

Loading

G1 Therapeutics vs. peers: Current Cash Comparison

Loading

G1 Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

G1 Therapeutics (GTHX) FAQ

G1 Therapeutics (GTHX) currently reports a current cash of $15M as of June 2024. That compares with $56M in the prior-year period — down 73.0% year over year. Use the charts on this page to explore G1 Therapeutics's current cash history and peer comparisons.

G1 Therapeutics's current cash decreased from $56M to $15M — a 73.0% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

G1 Therapeutics reported $15M in current cash as of June 2024. That compares with $56M in the prior-year period — down 73.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $15M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for G1 Therapeutics, and consider following GTHX for alerts when major investors trade the stock.

G1 Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $15M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GTHX with unrelated industries.